MicroPort

MicroPort is a mission-driven global medical device company with the goal of providing trustworthy, universal access to state-of-the-art solutions that prolong and reshape lives. Founded in 1998, it has grown into a diversified powerhouse with eight core business units, achieving significant regulatory milestones and commercial successes, including over 10 million coronary stent systems shipped and over 100 installations of its Toumai® surgical robot. Its strategy is built on a federated model of focused subsidiaries, a global R&D and manufacturing footprint, and a proprietary industrial ecosystem designed to foster innovation and streamline market access.

An integrated industrial ecosystem comprising a global R&D/manufacturing network and specialized platforms (Miracle Point incubator, CovalentBond Cloud for market expansion, All Bright for testing, AccuPath for manufacturing, and GloMatrix for global commercialization) designed to accelerate the entire medical technology lifecycle.